Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderHealthy Volunteers; Pandemic Influenza ImmunizationActive, not recruitingPhase 1 / Phase 22026-01-16NCT06907511

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Sanofi254

9 results · Page 1 of 1

Swipe the table sideways for more columns.